{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:17:50Z","timestamp":1791803870182,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12955-018-0893-z","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T11:06:30Z","timestamp":1524135990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Health-related quality of life in pediatric and adolescent patients with transfusion-dependent \u00df-thalassemia in upper Egypt (single center study)"],"prefix":"10.1186","volume":"16","author":[{"given":"Gehan L Abdel","family":"Hakeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan O","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa N","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H","family":"Mahgoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtesam E","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"893_CR1","doi-asserted-by":"crossref","unstructured":"Weatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.","DOI":"10.1002\/9780470696705"},{"key":"893_CR2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1056\/NEJMra050436","volume":"353","author":"D Rund","year":"2005","unstructured":"Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135\u201346. Article|PubMed|ISI|ChemPort","journal-title":"N Engl J Med"},{"key":"893_CR3","unstructured":"Cao A, Galanello R. Beta-thalassemia. Available at: \n                    http:\/\/www.geneclinics.org\n                    \n                  . Accessed 1 Dec 2005."},{"key":"893_CR4","unstructured":"Olivieri N, Weatherall DJ. Clinical aspects of \u03b2-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin, genetics, pathophysiology, and clinical management. Cambridge, England: Cambridge University, 2001;277\u2013341."},{"key":"893_CR5","first-page":"1193","volume":"91","author":"E Voskaridou","year":"2006","unstructured":"Voskaridou E, Anagnostopoulos A, Konstantopoulos K, et al. Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial. Haematologica. 2006;91:1193\u2013202.","journal-title":"Haematologica"},{"key":"893_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2141.2004.05143.x","volume":"127","author":"E Voskaridou","year":"2004","unstructured":"Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassemia. Br J Haematol. 2004;127:127\u201339. Article|PubMed|ChemPort","journal-title":"Br J Haematol"},{"key":"893_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1196\/annals.1345.051","volume":"1054","author":"R Origa","year":"2005","unstructured":"Origa R, Fiumana E, Gamberini MR, et al. Osteoporosis in beta-thalassemia: clinical and genetic aspects. Ann N Y Acad Sci. 2005;1054:451\u20136.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"893_CR8","first-page":"375","volume":"54","author":"A El Beshlawy","year":"2008","unstructured":"El Beshlawy A, Mokhtar G, Abd El Ghafar E, Abd El Dayem S, El-Sayed M, Aly A, Farok M. Assessment of puberty in relation to L-carnitine and hormonal replacement therapy in \u03b2-thalassemia patients. Tropical. Pediatrics. 2008;54(6):375\u201381.","journal-title":"Pediatrics"},{"key":"893_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0277-9536(00)00364-6","volume":"53","author":"K Atkin","year":"2001","unstructured":"Atkin K, Ahmad W. Living a \u201cnormal life\u201d: young people coping with thalassemia major or sickle cell disorder. Soc Sci Med. 2001;53:615\u201326.","journal-title":"Soc Sci Med"},{"key":"893_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2326-12-6","volume":"12","author":"G Caocci","year":"2012","unstructured":"Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E, Littera R, Markous RS, Collins GS, Ciceri F, Mandelli F, Marktel S, La Nasa G. Health-related quality of life in middle eastern children with beta-thalassemia. BMC Blood Disord. 2012;12:6.","journal-title":"BMC Blood Disord"},{"key":"893_CR11","volume-title":"Quality of life","author":"A Bowling","year":"2003","unstructured":"Bowling A. Current state of the art in quality of life measurement. In: Carr AJ, Higginson IJ, Robinson P, editors. Quality of life. London: BMJ Books; 2003."},{"issue":"7","key":"893_CR12","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/cncr.10428","volume":"94","author":"JW Varni","year":"2002","unstructured":"Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQLin pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer. 2002;94(7):2090\u2013106.","journal-title":"Cancer"},{"key":"893_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11136-005-1388-z","volume":"15","author":"JW Varni","year":"2006","unstructured":"Varni JW, Burwinkle TM, Seid M. The PedsQL 4.0 as a school population measure: feasibility, reliability, and validity. Qual Life Res. 2006;15:203\u201315.","journal-title":"Qual Life Res"},{"key":"893_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1196\/annals.1345.035","volume":"1054","author":"P Tefler","year":"2005","unstructured":"Tefler P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in Thalassaemia. Annals of the New York Academy of Science. 2005;1054:273\u201382. \n                    https:\/\/doi.org\/10.1196\/annals.1345.035\n                    \n                  .","journal-title":"Annals of the New York Academy of Science"},{"key":"893_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1196\/annals.1345.059","volume":"1054","author":"Z Pakbaz","year":"2005","unstructured":"Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. Quality of life in patients with Thalassaemia intermedia compared to Thalassaemia major. New York Academy of Sciences. 2005;1054:457\u201361. \n                    https:\/\/doi.org\/10.1196\/annals.1345.059\n                    \n                  .","journal-title":"New York Academy of Sciences"},{"key":"893_CR16","unstructured":"Guidelines for the management of non-transfusion dependent thalassemia (NTDT). Thalassaemia International Federation. 2013. Website: \n                    http:\/\/www.thalassaemia.org.cy\n                    \n                  ."},{"key":"893_CR17","unstructured":"Centers for Disease Control and Prevention. 2000. \n                    National Center for Health Statistics\n                    \n                  ."},{"key":"893_CR18","unstructured":"The PedsQL Measurement Model for the Pediatric Quality of Life Inventory. 2009. [\n                    http:\/\/www.pedsql.org\/about_pedsql.htm\n                    \n                  ]."},{"key":"893_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21101\/cejph.a3640","volume":"19","author":"MH Baghianimoghadam","year":"2011","unstructured":"Baghianimoghadam MH, Sharifirad G, Rahaei Z, Baghianimoghadam B, Heshmati H. Health-related quality of life in children with thalassemia assessed on the basis of SF-20 questionnaire in Yazd, Iran: a case\u2013control study. Cent Eur J Public Health. 2011;19:165\u20139.","journal-title":"Cent Eur J Public Health"},{"key":"893_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1477-7525-4-39","volume":"4","author":"A Ismail","year":"2006","unstructured":"Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health-related quality of life in Malaysian children with thalassemia. Health Qual Life Outcomes. 2006;4:39.","journal-title":"Health Qual Life Outcomes"},{"key":"893_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/bmt.2008.165","volume":"42","author":"DK Cheuk","year":"2008","unstructured":"Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL, Chan GC. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008;42:319\u201327.","journal-title":"Bone Marrow Transplant"},{"key":"893_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1600-0609.2011.01623.x","volume":"87","author":"KM Musallam","year":"2011","unstructured":"Musallam KM, Khoury B, Abi-Habib R, Bazzi L, Succar J, Halawi R, et al. the health-related quality of life in adults with transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major: new insights. Eur J Haematol. 2011;87:73\u20139.","journal-title":"Eur J Haematol"},{"issue":"1","key":"893_CR23","doi-asserted-by":"publisher","first-page":"e2012058","DOI":"10.4084\/mjhid.2012.058","volume":"4","author":"H Safizadeh","year":"2012","unstructured":"Safizadeh H, Farahmandinia Z, Nejad SS, Pourdamghan N, Araste M. Quality of life in patients with thalassemia major and intermedia in Kerman-Iran (I.R.). Mediterr J Hematol Infect Dis. 2012;4(1):e2012058.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"893_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1590\/1516-3180.2013.1313470","volume":"131","author":"S Haghpanah","year":"2013","unstructured":"Haghpanah S, Nasirabadi S, Ghaffarpasand F, Karami R, Mahmoodi M, Parand S, Karimi M. Sao Paulo Med J. 2013;131(3):166\u201372.","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"893_CR25","doi-asserted-by":"publisher","first-page":"e2012058","DOI":"10.4084\/mjhid.2012.058","volume":"4","author":"SS Nejad","year":"2012","unstructured":"Nejad SS, Pourdamghan N, Araste M. Quality of life in patients with thalassemia major and intermedia in Kerman-Iran (I.R.). Mediterr J Hematol Infect Dis. 2012;4(1):e2012058.","journal-title":"Mediterr J Hematol Infect Dis."},{"issue":"2","key":"893_CR26","first-page":"57","volume":"4","author":"SH Ansari","year":"2014","unstructured":"Ansari SH, Baghersalimi A, Azarkeivan A, Nojomi M, Hassanzadeh Rad A. Quality of life in patients with thalassemia major. Iran J Ped Hematol Oncol. 2014;4(2):57\u201363.","journal-title":"Iran J Ped Hematol Oncol"},{"key":"893_CR27","first-page":"186","volume":"7","author":"AM El Dakhakhny","year":"2011","unstructured":"El Dakhakhny AM, Hesham MA, Mohamed SE, Mohammad FN. Quality of life of school age thalassemic children at Zagazig City. J Am Sci. 2011;7:186\u201397.","journal-title":"J Am Sci"},{"key":"893_CR28","first-page":"1","volume":"10","author":"M Thavorncharoensap","year":"2010","unstructured":"Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disord. 2010;10:1.","journal-title":"BMC Blood Disord"},{"key":"893_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2214.2011.01224.x","volume":"38","author":"HF Gharaibeh","year":"2012","unstructured":"Gharaibeh HF, Gharaibeh MK. Factors influencing health-related quality of life of thalassaemic Jordanian children. Child Care Health Dev. 2012;38:211\u20138.","journal-title":"Child Care Health Dev"},{"key":"893_CR30","first-page":"10","volume":"99","author":"N Saeed","year":"2004","unstructured":"Saeed N. My life. United Kingdom Thalassemia Society Matters. 2004;99:10.","journal-title":"United Kingdom Thalassemia Society Matters"},{"key":"893_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0277-9536(02)00080-1","volume":"56","author":"D Cantaan","year":"2003","unstructured":"Cantaan D, Ratip S, Kaptan S, Cosan R. Psychological burden of beta thalassemia major in Antalya, South Turkey. Soc Sci Med. 2003;56:815\u20139.","journal-title":"Soc Sci Med"},{"key":"893_CR32","volume-title":"The politics of sickle cell and Thalassaemia","author":"E Anionwu","year":"2001","unstructured":"Anionwu E, Atkin K. The politics of sickle cell and Thalassaemia. Buckingham: Open University Press; 2001."},{"issue":"1","key":"893_CR33","first-page":"47","volume":"7","author":"M Naderi","year":"2012","unstructured":"Naderi M, Hormozi MR, Ashrafi M, Emamdadi A. Evaluation of mental health and related factors among patients with beta thalassemia major in south east of Iran. Iran j psychiatry. 2012;7(1):47\u201351.","journal-title":"Iran j psychiatry"},{"issue":"5","key":"893_CR34","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s12185-013-1322-z","volume":"97","author":"S Yahia","year":"2013","unstructured":"Yahia S, El-Hadidy MA, El-Gilany AH, Anwar R, Darwish A, Mansour AK. Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study. Int J Hematol. 2013;97(5):604\u20139.","journal-title":"Int J Hematol"},{"issue":"1","key":"893_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1442-200x.2004.02009.x","volume":"47","author":"Y Aydinok","year":"2005","unstructured":"Aydinok Y, Eremis S, Bukusoglu N, Yilmaz D, Solak U. Psychosocial implications of Thalassaemia major. Paediatr Int. 2005;47(1):84.","journal-title":"Paediatr Int"},{"issue":"5","key":"893_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1055\/s-2000-9683","volume":"212","author":"L Goldbeck","year":"2000","unstructured":"Goldbeck L, Baving A, Kohne E. Psychosocial aspects of beta thalassemia: distress, coping and adherence. Klinik Padiatrik. 2000;212(5):254\u20139.","journal-title":"Klinik Padiatrik"},{"key":"893_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.adolescence.2003.11.011","volume":"27","author":"A Mikelli","year":"2004","unstructured":"Mikelli A, Tsiantis J. Brief report: depressive symptoms and quality of life in adolescents with b-thalassaemia. J Adolesc. 2004;27:213\u20136.","journal-title":"J Adolesc"},{"key":"893_CR38","unstructured":"Coping in children with hemophilia and thalassemia: A cross-national study. 2010. [\n                    http:\/\/eprints.ecs.soton.ac.uk\n                    \n                  ]."},{"key":"893_CR39","first-page":"iii","volume":"13","author":"C McLeod","year":"2009","unstructured":"McLeod C, Fleeman N, Kirkham J, Bagust A, Boland A, Chu P, et al. Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anemia: a systematic review and economic evaluation. Health Technol Assess (Rockv). 2009;13:iii\u2013v.","journal-title":"Health Technol Assess (Rockv)"},{"key":"893_CR40","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/pbc.23413","volume":"58","author":"MS Elalfy","year":"2012","unstructured":"Elalfy MS, Massoud W, Elsherif NH, Labib JH, Elalfy OM, Elaasar S, et al. A new tool for the assessment of satisfaction with iron chelation therapy (ICT-sat) for patients with b-thalassemia major. Pediatr Blood Cancer. 2012;58:910\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"893_CR41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1445-5994.2011.02527.x","volume":"41","author":"PJ Ho","year":"2011","unstructured":"Ho PJ, Tay L, Lindeman R, Catley L, Bowden DK. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassemia major, sickle cell disease, and other congenital anemias. Intern Med J. 2011;41:516\u201324.","journal-title":"Intern Med J"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-018-0893-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-018-0893-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-018-0893-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:39:57Z","timestamp":1554838797000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-018-0893-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1186\/s12955-018-0893-z","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"18 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Available.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The study was conducted According to the declarations of Helsinki and approved from the faculty of medicine scientific committee.Written consents were obtained from patients\u2019 caregivers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"59"}}